KLRK1 is an activator of NK cell cytotoxicity, and NK cells have been shown to have a greater cytotoxic activity in individuals with cLBP [72] as well as spondyloarthritis [73]. This evidence concerns the gene KLRK1 and spondyloarthropathy.